| Caroline N Morales Santana, | |
|
Avenida Munoz Rivera, Edificio 309 Bo. Puente, Camuy, PR 00627-0061 | |
| (787) 915-3000 | |
| Not Available |
| Full Name | Caroline N Morales Santana |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Avenida Munoz Rivera, Camuy, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114507613 | NPI | - | NPPES |
| 6235673 | Other | PR | DRIVERS LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 004306 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caroline N Morales Santana, Po Box 347, Las Marias, PR 00670-0347 Ph: (787) 519-1389 | Caroline N Morales Santana, Avenida Munoz Rivera, Edificio 309 Bo. Puente, Camuy, PR 00627-0061 Ph: (787) 915-3000 |
News Archive
A unique approach to bone marrow transplantation pioneered in part by a Children's Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study.
New computer modeling work shows that by 2100, if society wants to limit carbon dioxide in the atmosphere to less than 40 percent higher than it is today, the lowest cost option is to use every available means of reducing emissions.
Connecticut now has more health benefit mandates than nearly all other states, a consultant told a state board Thursday. And when federal health reform rolls out in just over two years, that could leave the state, not the insurers, with a bill to pay. ... Although it's not yet clear what benefits federal government will require, as many as three-quarters of the benefits that Connecticut mandates could exceed what the federal government requires.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
Raquel Marrero Alfonzo, MS PHL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Carr 2 Km 92.3 Bo Membrillo Camuy, Camuy, PR 00627 Phone: 787-597-6367 | |
Amanda Morales, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 135 Ave Munoz Rivera E, E-suite 2, Camuy, PR 00627 Phone: 787-568-9915 | |
Mrs. Samir Charneco, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hc 5 Box 30395, Camuy, PR 00627 Phone: 787-378-9807 | |
Clinica Terapeutica Jeringonza Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 135 Ave Munoz Rivera E Ste 2, Camuy, PR 00627 Phone: 787-568-9915 | |
Xiomara Mercado Moya, PHL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 609 Urb Paseos De Camuy, D28, Camuy, PR 00627 Phone: 787-365-0234 | |
Mrs. Joselyn Perez Velez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Centro Plaza Leonardo Aviles, Camuy, PR 00627 Phone: 787-356-8048 |